Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZME4N)

Drug Name

BN-82685 Drug Info

Synonyms

UNII-YLE5P531SS; BN-82685; YLE5P531SS; IRC-083065; SCHEMBL1917819; 4,7-Benzothiazoledione, 5-((2-(dimethylamino)ethyl)amino)-2-methyl-; 5-((2-(Dimethylamino)ethyl)amino)-2-methyl-1,3-benzothiazole-4,7-dione; 477603-18-2

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 10286059
CAS Number: CAS 477603-18-2
TTD Drug ID: DMZME4N

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Discontinued Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting M-phase inducer phosphatase 3 (MPIP3)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
MX-7065	DMP26BW	Solid tumour/cancer	2A00-2F9Z	Terminated	[2]
BN-82002	DMXY574	Solid tumour/cancer	2A00-2F9Z	Investigative	[3]
NSC-663284	DMEXW31	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
M-phase inducer phosphatase 3 (MPIP3)	TTESBNC	MPIP3_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C. Bioorg Med Chem Lett. 2006 Jan 1;16(1):171-5.
2	Handbook of Assay Development in Drug Discovery, Lisa K. Minor, 2013. Page(11).
3	Synthesis of small molecule CDC25 phosphatases inhibitors. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5809-12.